---
$id: https://graph.org.ai/products/commodity/51282115
$type: Product
source: UNSPSC
code: "51282115"
title: "Oximonam"
class: "51282100"
classTitle: "Beta-lactams"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Oximonam

**UNSPSC Code**: 51282115
**Class**: [Beta-lactams](Beta-lactams.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-lactam antibiotic with the molecular formula C12H15N5O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 482M43SL0K, chemically known as acetic acid, ((3-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-methyl-4-oxo-1-azetidinyl)oxy)-, (2s-(2alpha,3beta(z)))- but generally known as oximonam, which bears US NIH Compound Identifier 9571070. European Medicines Agency schedules Oximonam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09531MIG. The term OXIMONAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). OXIMONAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oximonam under HS 29419000 and SITC 54139. As of Q4 2014, OXIMONAM remains the US FDA Preferred Term for this commodity. Oximonam bears US NLM identifiers UMLS ID C1882240 and NCI Concept Code C66266. SMILES: CC1C(C(=O)N1OCC(=O)O)NC(=O)C(=NOC)C2=CSC(=N2)N.

